Change in vBMD of Combination Therapy of Teriparatide and Denosumab in Osteoporosis at 18 Months: How Much Difference Does It Make on Spine vBMD?

Key Points

• Combination therapy with teriparatide and denosumab significantly improves spine vBMD.
• Participants experienced a noteworthy increase in vBMD after 18 months of treatment.
• Assessment included measurements of vBMD following therapeutic intervention.
• Findings suggest that the combination therapy could enhance bone health in osteoporosis.